(Q70075078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1

G Mathé

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

M Hayat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

L Schwarzenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J L Amiel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

M Schneider

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A Cattan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J R Schlumberger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

C Jasmin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

language of work or name

English

0 references

publication date

1 August 1967

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

7512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

380-382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

Rubidomycin. A new agent active in the treatment of acute lymphoblastic leukaemia

8 October 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2867%2992004-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(67)92004-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4166329%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference